James L Zellner, MD, Scott B Kribbs, BS, B

Slides:

Advertisements

Similar presentations

Aortic Valve Replacement With Patch Enlargement of the Aortic Annulus

Advertisements

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.

Ten-year trends in heart valve replacement operations

Repeat Sternotomy: No Longer a Risk Factor in Mitral Valve Surgical Procedures Mehrdad Ghoreishi, MD, Murtaza Dawood, MD, Gerald Hobbs, PhD, Chetan Pasrija,

Leena Khaitan, MD, Francis P Sutter, Scott M Goldman, MD

Reduction of the Inflammatory Response in Patients Undergoing Minimally Invasive Coronary Artery Bypass Grafting Y.John Gu, Massimo A Mariani, Willem.

Puja Gaur, MD, Tsuyoshi Kaneko, MD, Siobhan McGurk, BS, James D

Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery Farkas B. Vánky, MD, PhD, Erik.

Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M

Jeffrey G. Gaca, MD, Shubin Sheng, PhD, Mani Daneshmand, MD, J

G. James Avery, MD, S. Jill Ley, RN, J

Bashir M Matata, PhD, Andrzej W Sosnowski, MD, Manuel Galiñanes

Ten-year trends in heart valve replacement operations

Penehyclidine hydrochloride preserves the intestinal barrier function in patients undergoing cardiopulmonary bypass Ying-jie Sun, PhD, Dan-dan Song,

Leukocyte depletion during cardiac operation: a new approach through the venous bypass circuit Y.John Gu, MD, PhD, A.J de Vries, MD, Paulien Vos, Piet.

Coronary artery operation in patients after breast cancer therapy

Pain and quality of life after minimally invasive versus conventional cardiac surgery Thomas Walther, MD, Volkmar Falk, MD, Sebastian Metz, Anno Diegeler,

Steven R. Gundry, MD, Matthew A. Romano, MD, O

Current determinants of operative mortality in 1400 patients requiring aortic valve replacement Ines Florath, PhD, Ulrich P Rosendahl, MD, Amir Mortasawi,

Susanne Lison, MD, Michael Spannagl, MD, PhD, Wulf Dietrich, MD, PhD

Potassium and Magnesium Supplementation Do Not Protect Against Atrial Fibrillation After Cardiac Operation: A Time-Matched Analysis Timothy S. Lancaster,

Definition of postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass: One size doesn't fit all David Faraoni, MD,

Mariano E. Brizzio, MD, Alex Zapolanski, MD, Richard E

Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery John L Francis, PhD, George J Palmer, MD, Rebecca Moroose,

Brain SPECT imaging and neuropsychological testing in coronary artery bypass patients R.Alan Hall, MD, David J Fordyce, PhD, Marie E Lee, MD, Brian Eisenberg,

Comparative effects of propofol versus fentanyl on cerebral oxygenation state during normothermic cardiopulmonary bypass and postoperative cognitive dysfunction

John S. Ikonomidis, MD, PhD, Ebony J

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.

Natural history of coexistent tricuspid regurgitation in patients with degenerative mitral valve disease: Implications for future guidelines Andrew B.

Are older patients with mechanical heart valves at increased risk?

Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response Martin Westerberg, MD, Anders.

Endothelin-1 during and after cardiopulmonary bypass: Association to graft sensitivity and postoperative recovery Brian R. Bond, PhD, B.Hugh Dorman,

Aortic Valve Bypass for the High-Risk Patient With Aortic Stenosis

Brian R Bond, PhD, James L Zellner, MD, B

Repeat Sternotomy: No Longer a Risk Factor in Mitral Valve Surgical Procedures Mehrdad Ghoreishi, MD, Murtaza Dawood, MD, Gerald Hobbs, PhD, Chetan Pasrija,

Michel Carrier, MD, Michel Pellerin, MD, Louis P Perrault, MD, PhD, B

Infant cardiopulmonary bypass: a procoagulant state

Cassandra Joffs, MD, Himali R. Gunasinghe, BS, Marlina M

Anticoagulation with bivalirudin during cardiopulmonary bypass in cardiac surgery Julio C Vasquez, MD, Anna Vichiendilokkul, PharmD, Syed Mahmood, MD,

Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD

Kai Ihnken, MD The Journal of Thoracic and Cardiovascular Surgery

High Flow Rates During Modified Ultrafiltration Decrease Cerebral Blood Flow Velocity and Venous Oxygen Saturation in Infants Rosendo A. Rodriguez, MD,

A. Thomas Pezzella, MD, Sari D

Safety and efficacy of a heparin removal device: a prospective randomized preclinical outcomes study Joseph B Zwischenberger, MD, Weike Tao, MD, Donald.

Time course of proinflammatory and anti-inflammatory responses after cardiac operation: monocyte HLA-DR expression Y.John Gu, MD, PhD, Willem van Oeveren,

Effect of modified ultrafiltration on plasma thromboxane B2, leukotriene B4, and endothelin-1 in infants undergoing cardiopulmonary bypass Jeffrey M.

Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair Greg Stratmann, MD, PhD, Isobel A Russell,

Optimizing Mitral Valve Exposure With Conventional Left Atriotomy

Anthony P.C Yim, MD, Song Wan, MD, PhD, Tak Wai Lee, Ahmed A Arifi

Stroke in cardiac surgical patients: determinants and outcome

Preoperative Intraaortic Balloon Pump Enhances Cardiac Performance and Improves the Outcome of Redo CABG Jan T. Christenson, MD, PhD, Pierre Badel, MD,

Aprotinin Enhances the Endogenous Release of Interleukin-10 After Cardiac Operations Gary E Hill, Robert P Diego, Alfred H Stammers, Suzanne M Huffman,

Minimally Invasive Port Access Approach for Reoperations on the Mitral Valve Prashanth Vallabhajosyula, MD, MS, Tyler Wallen, DO, Aaron Pulsipher, BS,

Randomized Controlled Trial of Pericardial Blood Processing With a Cell-Saving Device on Neurologic Markers in Elderly Patients Undergoing Coronary Artery.

Aprotinin is Not Associated With Postoperative Renal Impairment After Primary Coronary Surgery Gabriella Lindvall, MD, Ulrik Sartipy, MD, PhD, Torbjörn.

Transapical Arterial Cannulation for Salvage Cardiopulmonary Bypass in Transcatheter Aortic Valve Replacement Derek R. Brinster, MD, Jay A. Patel, Harry.

Potassium and Magnesium Supplementation Do Not Protect Against Atrial Fibrillation After Cardiac Operation: A Time-Matched Analysis Timothy S. Lancaster,

A special adapted retractor for the mini-sternotomy approach

Conduction disturbances after superior septal approach for mitral valve repair Yoshio Misawa, MD, PhD, Katsuo Fuse, MD, Koji Kawahito, MD, Tsutomu Saito,

Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient

Influence of concomitant CABG and urgent/emergent status on mitral valve replacement surgery Vinod H Thourani, MD, William S Weintraub, MD, Joseph M.

Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS

Can late survival of patients with moderate ischemic mitral regurgitation be impacted by intervention on the valve? Kevin M Harris, MD, Thoralf M Sundt,

Neutrophil CD11b upregulation during cardiopulmonary bypass is associated with postoperative renal injury Christine S Rinder, MD, Manuel Fontes, MD,

Karl A. Bocchieri, BS, CCP, S. Jacob Scheinerman, MD, L

Safety of low hematocrits during cardiopulmonary bypass

Y.John Gu, MD, PhD, Piet W. Boonstra, MD, PhD, Willem van Oeveren, PhD

A randomized trial of antithrombin concentrate for treatment of heparin resistance Mathew R Williams, MD, Alyssa B D’Ambra, BA, James R Beck, Talia B.

Revascularization alone (without mitral valve repair) suffices in patients with advanced ischemic cardiomyopathy and mild-to-moderate mitral regurgitation

Reoperative mitral valve replacement: importance of preservation of the subvalvular apparatus Michael A Borger, MD, PhD, Terrence M Yau, MD, MS, Vivek.

Presentation transcript:

Cardiopulmonary bypass in a gravid patient: perioperative changes in endothelin levels James L Zellner, MD, Scott B Kribbs, BS, B.Hugh Dorman, MD, PhD, Francis G Spinale, MD, PhD The Annals of Thoracic Surgery Volume 66, Issue 1, Pages 268-270 (July 1998) DOI: 10.1016/S0003-4975(98)00383-X

Fig 1 Perioperative changes in venous and arterial plasma endothelin levels in a gravid patient undergoing mitral valve replacement. Plasma endothelin levels before and during cardiopulmonary bypass (CPB) were consistently elevated above baseline levels. Further elevations in plasma endothelin level occurred after weaning from CPB, with levels increased to more than twice the baseline level at 24 hours postoperatively. At 36 hours postoperatively, arterial plasma endothelin level decreased, yet remained elevated above baseline levels. The Annals of Thoracic Surgery 1998 66, 268-270DOI: (10.1016/S0003-4975(98)00383-X)